These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6398775)

  • 1. The QSAR paradigm in the design of less toxic molecules.
    Hansch C
    Drug Metab Rev; 1984-1985; 15(7):1279-94. PubMed ID: 6398775
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 3. Organic nitrates. O-(2,3-dihydroxypropyl)-1,4:3,6-dianhydro-hexitol-nitrates.
    Stoss P; Schlüter G; Axmann R
    Arzneimittelforschung; 1990 Jan; 40(1):13-8. PubMed ID: 2339994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine].
    Hagen V; Klauschenz E; Rumler A; Niedrich H; Hagen A; Heer S; Mitzner R
    Pharmazie; 1990 May; 45(5):343-5. PubMed ID: 2395896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship investigation of bis(2-chloroethyl)aminoethyl esters of some carboxylic acids.
    Pajeva I; Manolov I; Golovinsky EV
    Pharmazie; 1990 May; 45(5):361-3. PubMed ID: 2395899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in searching for antitumor compounds.
    Preobrazhenskaya MN
    Natl Cancer Inst Monogr; 1977 Mar; (45):195-205. PubMed ID: 337151
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiochemical drug properties associated with in vivo toxicological outcomes.
    Hughes JD; Blagg J; Price DA; Bailey S; Decrescenzo GA; Devraj RV; Ellsworth E; Fobian YM; Gibbs ME; Gilles RW; Greene N; Huang E; Krieger-Burke T; Loesel J; Wager T; Whiteley L; Zhang Y
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4872-5. PubMed ID: 18691886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS.
    Kutter E; Austel V
    Arzneimittelforschung; 1981; 31(1a):135-41. PubMed ID: 7195206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential antitumor agents. 24. Synthesis and pharmacological behavior of imidazo[2,1-b]thiazole guanylhydrazones bearing at least one chlorine.
    Andreani A; Rambaldi M; Leoni A; Locatelli A; Bossa R; Fraccari A; Galatulas I; Salvatore G
    J Med Chem; 1996 Jul; 39(14):2852-5. PubMed ID: 8709115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking toxicity and chemistry: think globally, but act locally?
    Johnson DE; Smith DA; Park BK
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):33-5. PubMed ID: 14982145
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advances in drug design].
    Guo ZR
    Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):238-44. PubMed ID: 6393337
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of quantum chemistry in the development and analysis of anticancer drugs.
    Christoffersen RE
    Cancer Chemother Rep 2; 1974 Dec; 4(4):47-8. PubMed ID: 4447933
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
    Siraki AG; Chevaldina T; Moridani MY; O'Brien PJ
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):118-25. PubMed ID: 14982155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
    Dumont P; Fuks R; Atassi G; Hanocq M
    J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship between chemical structure and pharmacodynamic activity].
    Tronchet JM
    Pharm Acta Helv; 1973; 48(8):482-8. PubMed ID: 4766789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and cardiotonic activities of 5-substituted-4-methyl-1,3- dihydro-2H-imidazol-2-ones].
    Chen YH; Sun CS; Rui YC
    Yao Xue Xue Bao; 1988 Jan; 23(1):21-7. PubMed ID: 3400472
    [No Abstract]   [Full Text] [Related]  

  • 18. The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicity.
    Fink SI; Leo A; Yamakawa M; Hansch C; Quinn FR
    Farmaco Sci; 1980 Dec; 35(12):965-79. PubMed ID: 7202703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thoughts on the development of drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):676-97. PubMed ID: 4576436
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.